The notion “diabetes” refers to a disease impacting the body’s ability to produce/use insulin. At present, more than 365 million people suffer from the disease worldwide. By 2030, the figure may reach 550 million. Inappropriate eating habits combined with a sedentary lifestyle, growth of the diabetic population and an increase in the number of obesity cases are amid the main factors contributing to the diabetes market growth. The list of the products available on the market is extensive: continuous blood glucose meters, anti-diabetic drugs, insulin and insulin pumps, artificial pancreas devices, etc.
Evaluated at over USD 19.8 billion, North America represents the top market, while Europe acts as the second largest player. The global diabetes market is expected to be at approximately USD 100 billion in 2018, showing a twofold increase if compared to 2011.
The Catalogue includes research reports dedicated to the diabetes market. The studies describe past and current industry trends, disclose data on the market competition and profile top industry behemoths. Information on the upcoming market events, industry growth drivers and hindrances can be found in the reports, too. Besides, the research reports contain evaluation of the actual economic situation, analyses of the market prospects.
Publications found:
84
Sort by:
Global Oral Diabetes Medicine Market Growth 2026-2032
US$ 3,660.00
The global Oral Diabetes Medicine market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032. United States market for Ora...
September 2026
115 pages
Global Exhaust Gas Hose Market Growth 2026-2032
US$ 3,660.00
The global Exhaust Gas Hose market size is predicted to grow from US$ 1835 million in 2025 to US$ 2563 million in 2032; it is expected to grow at a CAGR of 5.0% from 2026 to 2032. The exhaust gas hose...
September 2026
115 pages
Global Prediabetes Market Size Study and Forecast by Drug Class (Biguanide, Thiazolidinediones, Glucagon-like Peptide-1 Agonists (GLP-1), SGLT2 Inhibitors, DPP-4 Inhibitors, Others), by Age Group (Children (12–18 years), Adults (18–49), Elderly (50+)), and Regional Forecasts 2026–2036
US$ 3,750.00
The Global Prediabetes Market, valued at USD 349.50 Million in 2025, is anticipated to reach USD 965.04 Million by 2036, expanding at a 9.5% CAGR during the forecast period. The prediabetes market con...
August 2026
285 pages
Digital Diabetes Management Market Forecasts to 2034 – Global Analysis By Product (Devices, Software & Platforms, and Services), Device Connectivity, Diabetes Type, Distribution Channel, Deployment Mode, End User and By Geography
US$ 4,150.00
According to Stratistics MRC, the Global Digital Diabetes Management Market is accounted for $8.2 billion in 2026 and is expected to reach $24.6 billion by 2034, growing at a CAGR of 14.7% during the...
June 2026
200 pages
Prediabetes Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Drug Class (Biguanide, Thiazolidinediones, Glucagon-like peptide-1 agonists (GLP-1), SGLT2 inhibitors, DPP-4 inhibitors, Others), By Age Group (Children (12-18 years), Adults (18-49), Elderly (50+)), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Prediabetes Market is projected to expand significantly, increasing from USD 351.71 million in 2025 to USD 664.63 million by 2031, demonstrating an impressive compound annual growth rate (C...
May 2026
180 pages
Japan Diabetes Market Report: 2026-2034
US$ 2,999.00
... of 4.4% during 2011-2018. The market is further projected to cross US$ 5 Billion by 2024, growing at a CAGR of 3.8% during 2019-2024. Diabetes refers to a chronic disease in which ... in the industry. Key Questions Answered in This Report: How has the Japan diabetes market performed so far and how will it perform ...
April 2026
139 pages
Canada Diabetes Market Report: 2026-2034
US$ 2,999.00
IMARC’s new report “Canada Diabetes Market Report: 2018-2023” provides an analytical and statistical insight into the Canada diabetes market. The report provides both current and future trends in the prevalence, demographical ...
February 2026
149 pages
Diabetic Ketoacidosis Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Treatment (Insulin Therapy, Electrolyte Replacement, Fluid Replacement), By End User (Hospitals & Clinics, Ambulatory Care Centers, Others) By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Diabetic Ketoacidosis Market is projected to expand from USD 3.37 Billion in 2025 to USD 4.68 Billion by 2031, achieving a compound annual growth rate of 5.63%. This market covers essential...
January 2026
185 pages
Global Markets for Diabetes Therapeutics and Diagnostics
US$ 4,650.00
This BCC Research report provides detailed market, technology and industry analyses of the market for drugs used in the treatment of diabetes, as well as the devices and instruments used for diagnosis and monitoring of diabetes. Forecast provided from 2016 through 2021.
January 2026
187 pages
Global Diabetic Macular Edema Market - 2025 -2033
US$ 4,350.00
Diabetic Macular Edema Market Size Diabetic Macular Edema Market Size reached US$4.91 Billion in 2024 and is expected to reach USnbsp; 7.44 Billion by 2033, growing at a CAGR of 4.8% during the foreca...
October 2025
180 pages
Global Diabetic Neuropathy Market - 2025 -2033
US$ 4,350.00
Diabetic Neuropathy Market Size and Growth The global diabetic neuropathy market reached US$ 4.47 billion in 2023, with a rise of US$ 4.74 billion in 2024, and is expected to reach US$ 8.40 billion by...
October 2025
180 pages
Diabetes Management Apps Market Size, Share & Trends Analysis Report By Type (Type 1 Diabetes, Type 2 Diabetes), By Functionality, By Platform, By Subscription Model, By End Use, By Region, And Segment Forecasts, 2025 - 2030
US$ 5,950.00
This report can be delivered to the clients within 3 Business Days Diabetes Management Apps Market Trends The global diabetes management apps market was estimated at USD 1.87 billion in 2024 and is...
May 2025
100 pages
Hemoglobin A1c Testing Devices Market - 2025-2033
US$ 3,400.00
Hemoglobin A1c Testing Devices Marketis is growing with a CAGR of 8.80% during the forecast period 2026-2035. The Hemoglobin A1c Testing Devices Market emerges as a key focus in DataM Intelligence lat...
January 2025
56 pages
Diabetic Nephropathy Market - 2024-2031
US$ 3,400.00
Diabetic Nephropathy Marketis is growing with a CAGR of 6.20% during the forecast period 2026-2035. The Diabetic Nephropathy Market emerges as a key focus in DataM Intelligence latest in-depth analysi...
October 2024
46 pages
Brazil Diabetes Market Report: 2024-2032
US$ 2,999.00
IMARC’s new report “Brazil Diabetes Market Report: 2019-2024” provides an analytical and statistical insight into the Brazil diabetes market. The report provides both current and future trends in the prevalence ...
July 2024
138 pages
Global Diabetes Insulin Delivery Pen Market 2022: Insights, Trends, Competition, Growth Opportunities, Market Size, Market Share Data, Analysis Outlook and Forecast to 2028
US$ 1,990.00
Amid the COVID-19 crisis, the global diabetes insulin delivery pen market size is expected to grow from an estimated value of USD 16,975 million in 2022 to USD 22,170 million by 2028. After conducting...
September 2022
290 pages
Diabetes Associated Ophthalmic Treatment Market Size, Share & Trends Analysis Report By Type (Drugs, Devices), By Application (Dry Eye, Glaucoma, Diabetic Retinopathy, DAMD, Uveitis, Cataract), By End-use, By Region, And Segment Forecasts, 2021 - 2028
US$ 5,950.00
This report can be delivered to the clients within 72 Business Hours Diabetes Associated Ophthalmic Treatment Market Growth & Trends The global diabetes associated ophthalmic treatment market size i...
October 2021
178 pages
Global Type 2 Diabetes Treatment Market Research and Forecast, 2018-2023
US$ 3,600.00
... treatment therapies for diabetes and a strict regulatory framework that hamper the growth of the global type 2 diabetes market. Based on the region, the global type 2 diabetes ... of the World. North America dominates the global type 2 diabetes market owing to technological advancements and supportive government ...
January 2019
-
Diabetic Foot Ulcer (DFU) Market & Drug Pipeline Analysis - Forecast to 2025
US$ 4,950.00
“Diabetic Foot Ulcer (DFU) Pipeline Analysis” gives comprehensive insights on the various drugs being developed for the treatment of DFU. The ... research for DFU. Market Data Forecasting model for DFU market DFU market dynamics DFU Market Sizing DFU related deals & Funding scenario in DFU market Pipeline Analysis ...
December 2018
136 pages
U.S. Next Generation Diabetes Therapy and Drug Delivery Market by Product Type (Inhalable Insulin, Oral Insulin, Insulin Patch, CGM System, and Artificial Pancreas), Demographic (Adult Population and Child Population), Indication (Type I Diabetes and Type II Diabetes), and End User (Diagnostics/Clinic, ICU, and Home Healthcare) - U.S. Opportunity Analysis and Industry Forecast, 2014-2023
US$ 3,255.00
... skin irritation due to frequent use of needles. The U.S. next generation diabetes therapy and drug delivery market is segmented based on product type, ... analysis of the key developments in the industry. The U.S. next generation diabetes therapy and drug delivery market is comprehensively analyzed with respect to ...
April 2018
124 pages
Global Human Insulin Market 2018-2024
US$ 2,750.00
... for the manufacturers of human insulin. Market Analysis: The “Global Human Insulin” market is estimated to witness a CAGR of 10.2% during the forecast period 2017–2023. The human insulin market is analyzed based on three ...
February 2018
77 pages
Medical Affairs Reputations: Type 2 Diabetes Mellitus [Orals] (EU5) 2018
US$ 6,365.00
... the market leader In the EU5, several of the Type 2 Diabetes Mellitus medical affairs teams we surveyed are running neck and neck with ... ways you can improve your medical affair services in Medical Affairs Reputations: Type 2 Diabetes Mellitus (Orals) (EU5). Comparing 9 major Type 2 Diabetes Mellitus (Orals) ...
January 2018
-
India Diabetes Market Report 2017
US$ 2,350.00
... still maintained a relatively optimistic growth, the past four years, Diabetes market size to maintain the average annual growth rate of 1.96% from 401 ... ) Channel (Direct Sales, Distributor) Segmentation Section 7: 400 USD - Trend (2017-2021) Section 8: 300 USD - Product Type Detail Section 9: 700 ...
November 2017
126 pages
NPS+ Type 2 Diabetes Mellitus [2017] EU5
US$ 2,575.00
... does each of the leading brands compare to its competitors? NPS+ Type 2 Diabetes Mellitus (EU5) gives a unique insight into the overall brand health ... degludec/liraglutide; Novo Nordisk) Explore Important Brand Loyalty Issues NPS+ Type 2 Diabetes Mellitus (EU5) offers valuable insight into brand loyalty from ...
August 2017
-
NPS+ Type 2 Diabetes Mellitus [2017] US
US$ 2,575.00
... how does each of the leading brands compare to its competitors? NPS+ Type 2 Diabetes Mellitus (US) gives a unique insight into the overall brand health of ... (liraglutide; Novo Nordisk) Explore Important Brand Loyalty Issues NPS+ Type 2 Diabetes Mellitus (US) offers valuable insight into brand loyalty from the ...
August 2017
-
Medical Affairs Reputations: Type 2 Diabetes Mellitus (US)
US$ 6,175.00
Find out what the leading medical affairs teams in type 2 diabetes are doing right Medical affairs teams for several leading T2DM treatments in the US ... your team gets right, and where it’s going wrong in Medical Affairs Reputations: Type 2 Diabetes Mellitus (US). Comparing 11 major melanoma treatments from ...
June 2017
-
